- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
Patent holdings for IPC class A61K 31/706
Total number of patents in this class: 1685
10-year publication summary
|
90
|
122
|
136
|
116
|
145
|
157
|
288
|
257
|
219
|
50
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1879 |
62 |
| Nuvamid SA | 54 |
41 |
| Celgene Corporation | 1412 |
32 |
| Société des Produits Nestlé S.A. | 9672 |
30 |
| Elysium Health, Inc. | 74 |
22 |
| The Johns Hopkins University | 5377 |
21 |
| ChromaDex Inc. | 84 |
21 |
| The Regents of the University of California | 18943 |
19 |
| Otsuka Pharmaceutical Co., Ltd. | 1426 |
19 |
| Washington University | 1473 |
19 |
| Metro International Biotech, LLC | 35 |
19 |
| Novartis AG | 11238 |
18 |
| Cornell University | 3036 |
17 |
| Centre National de La Recherche Scientifique | 9632 |
15 |
| Ohara Pharmaceutical Co., Ltd. | 35 |
14 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
13 |
| Deciphera Pharmaceuticals, LLC | 177 |
12 |
| Emory University | 1498 |
12 |
| Merck Sharp & Dohme LLC | 3689 |
12 |
| Genentech, Inc. | 3742 |
11 |
| Other owners | 1256 |